We look forward to seeing you in Brno.
Dear colleagues and friends,
as we enter the summer months, we are already looking forward to seeing you in Brno from September 9 to 11, 2026, for the 50th anniversary edition of the Brno Oncology Days. To mark this special anniversary, we have, as is our tradition, prepared a rich professional program for you. We will open it together with world-renowned expert and former president of the European Society for Medical Oncology (ESMO) Andrés Cervantes.
In addition to educational sessions dedicated to specific types of cancer, we will also address issues related to young cancer patients and hereditary cancer syndromes. Other topics include data in oncology, telemedicine, and artificial intelligence, as well as organizational aspects of surgical care. The topic of prevention also runs through several of the sessions.
We would like to invite you to the International Brno Oncology Days, where our guests will include professor Nadia Harbeck, a specialist in breast cancer, and Elizabeth Smyth, a leading expert in the treatment of gastrointestinal tumors. The international segment will cover topics such as precision oncology and issues related to the Survivorship program.
The program for our ESMO accredited conference has now been fully updated here on the website. We would also like to remind you that the deadline for conference registration is August 31, 2026.
Have a relaxing summer, we look forward to seeing you at the Brno Oncology Days!
Dates of BOD conference:
9-11 September 2026
Networking Brings Professionals Together
Join us in Brno and network with your colleagues, interact with key opinion leaders, ask questions, and debate burning topics in the field of medical oncology in a uniquely meaningful way.
Brno Oncology Days
Brno Oncology Days (BOD) is known for convening oncology experts in a friendly setting for three days of inspiring, innovative discussion on the most relevant challenges in oncology and for multidisciplinary meetings, treatment standards/guidelines, educational and scientific sessions. The conference objectives are designed to introduce the audience to the standard of care but also the latest information on modern therapies and emerging treatments in early development.
